Retention of supraspinal delta-like analgesia and loss of morphine tolerance in δ opioid receptor knockout mice

Neuron

Volumn 24, Issue 1, 1999, Pages 243-252

  Zhu, Yanxin ^a   King, Michael A ^b   Schuller, Alwin G P ^a   Nitsche, Joshua F ^a   Reidl, Maureen ^c   Elde, Robert P ^c   Unterwald, Ellen ^d   Pasternak, Gavril W ^b   Pintar, John E ^a  

^a University of Medicine and Dentistry   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 CYSTEINE]; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALTRINDOLE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE TARGETING; IMMUNOCYTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KNOCKOUT MOUSE; MORPHINE TOLERANCE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033198831     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80836-3     Document Type: Article

References (44)

1. Abdelhamid, E.E., Sultana, M., Portoghese, P.S., and Takemori, A.E. (1991). Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. f Pharmacol. Exp. Ther. 258, 299-303.
2. Arvidsson, U., Dado, R.J., Law, P.-Y., Loh, H.H., Elde, R., and Wessendorf, M.W. (1995). Delta (δ) -opioid receptor immunoreactivity: distribution in brain stem and spinal cord and relationship to biogenic amines. J. Neurosci. 15, 1215-1235.
3. Calcagnetti, D.J., Helmsetter, F.J., and Fanselow, M.S. (1988). Analgesia produced by centrally administered DAGO, DPDPE, and U50488H in the formalin test. Eur. J. Pharmacol. 153, 117-122.
4. Chang, K.-J., Rigdon, G.C., Howard, J.L., and McNull, R.W. (1993). A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J. Pharmacol. Exp. Ther. 267, 852-857.
5. Cowan, A., Zhu, X.Z., Mosberg, H.I., Omnaas, J.R., and Porreca, F. (1988). Direct dependence studies in rats with agents selective for different types of opioid receptor. J. Pharmacol. Exp. Ther. 246, 950-955.
6. Ellison, N.M. (1993). Opioid analgesics for cancer pain: toxicities and their treatments. In Cancer Pain, R.B. Patt, ed. (Philadelphia: J. P. Lipincott), pp. 185-194.
7. Evans, C.J., Keith, D.E., Jr., Morrison, H., Magendzo, K., and Edwards, R.H. (1992). Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
8. Haley, T.J., and McCormick, W.G. (1957). Pharmacological effects produced by intracerebroventricular injection of drugs into the conscious mouse. Br. J. Pharmacol. Chemother. 12, 12-15.
9. Hepburn, M.J., Little, P.J., Gingras, J., and Kuhn, C.M. (1997). Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats. J. Pharmacol. Exp. Ther. 281, 1350-1356.
10. Herz, A. (1993). Opioids, Handbook of Experimental Pharmacology, Volume 114 (New York: Springer-Verlag).
11. Heyman, J.S., Mulvaney, S.A., Mosberg, H.I., and Porreca, F. (1987). Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res. 420, 100-108.
12. Heyman, J.S., Vaught, J.L., Raffa, R.B., and Porreca, F. (1988). Can supraspinal delta-opioid receptors mediate antinociception? Trends Pharmacol. Sci. 9, 134-138.
13. Miller, J.M., Fan, L.Q., and Simon, E.J. (1996). Autoradiographic comparison of [3H]DPDPE and [3H]DSLET binding: evidence for distinct delta 1 and delta 2 opioid receptor populations in rat brain. Brain Res. 719 85-95.
14. Hylden, J.L., and Wilcox, G.L. (1980). Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67, 313-316.
15. Kest, B., Lee, C.E., McLenmore, G.L., and Inturrisi, C.E. (1996). An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res. Bull. 39, 185-189.
16. Kieffer, B.L. (1995). Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615-635.
17. Kieffer, B.L., Befort, K., Gaveriaux-Ruff, C., and Hirth, C.G. (1992). The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
18. Konig, M., Zimmer, A.M., Steiner, H., Holmes, P.V., Crawley, J.N., Brownstein, M.J., and Zimmer, A. (1996). Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383, 535-538.
19. Luke, M.C., Hahn, E.F., Price, M., and Pasternak, G.W. (1988). Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci. 43, 1249-1256.
20. Maldonado, R., Negus, S., and Koob, G.F. (1992). Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta-and kappa-selective opioid antagonists. Neuropharmacology 31, 1231-1241.
21. Mansour, A., Thompson, R.C., Akil, H., and Watson, S.J. (1993). Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA. J. Chem. Neuroanat. 6, 351-362.
22. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dolle, P., et al. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383, 819-823.
23. Mattia, A., Farmer, S.C., Takemori, A.E., Sultana, M., Portoghese, P.S., Mosberg, H.I., Bowen, W.D., and Porreca, F. (1992). Spinal opioid delta antinociception in the mouse: mediation by a 5′-NTII-sensitive delta receptor subtype. J. Pharmacol. Exp. Ther. 260, 518-525.
24. Mattia, A., Vanderah, T., Mosberg, H.I., and Porreca, F. (1991). Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258, 583-587.
25. Munson, P.F., and Rodbar, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
26. Olianas, M.C., and Onali, P. (1995). Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb. J. Pharmacol. Exp. Ther. 275, 1560-1567.
27. Pasternak, G.W. (1993). Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16, 1-18.
28. Portoghese, P.S., Sultana, M., and Takemori, A.E. (1988). Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146, 185-186.
29. Rapaka, R.S., and Porreca, F. (1991). Development of delta opioid peptides as nonaddicting analgesics. Pharm. Res.8, 1-8.
30. Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G.I., and Reisine, T. (1994). Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol. 45, 330-334.
31. Rossi, G.C., Su, W., Leventhal, L., Su, H., and Pasternak, G.W. (1997). Antisense mapping DOR-1 in mice: further support for delta receptor subtypes. Brain Res. 753, 176-179.
32. Roy, S., Barke, R.A., and Loh, H.H. (1998). MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res. Mol. Brain Res. 61, 190-194.
33. Rubinstein, M., Mogil, J.S., Japon, M., Chan, E.C., Allen, R.G., and Low, M.J. (1996). Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 93, 3995-4000.
34. Schuller, A.G.P., King, M., Zhang, J., Bolan, E., Pan, Y.-X., Morgan, D.J., Czick, M.E., Chang, A., Unterwald, E., Pasternak, G.W., and Pintar, J.E. (1999). Retention of heroin and morphine-6β-glucuronide analgesia in a novel line of MOR-1 exon 1 knockout mice. Nat. Neurosci, 2, 151-156.
35. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B.P., Maldonado, R., and Kieffer, B.L. (1998). Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17, 886-897.
36. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R.S., Donovan, D.M., Miner, L.L., and Uhl, G.R. (1997). Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA 94, 1544-1549.
37. Standifer, K.M., Chien, C.C., Wahlestedt, C., Brown, G.P., and Pasternak, G.W. (1994). Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12, 805-810.
38. Tian, M.T., Broxmeyer, H.E., Fan, Y., Lai, Z.N., Zhang, S.W., Aronica, S., Cooper, S., Bigsby, R.M., Steinmetz, R., Engle, S.J., et al. (1997). Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J. Exp. Med. 185, 1517-1522.
39. Tiseo, P.J., and Yaksh, T.L. (1993). Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat. Eur. J. Pharmacol. 236, 89-96.
40. Unterwald, E.M., Rubenfeld, J.M., and Kreek, M.J. (1994). Repeated cocaine administration regulates kappa and mu, but not delta, opioid receptors. Neuroreport 5 1613-1616.
41. Wild, J.D., McCormick, J., Bilsky, E.J.. Vanderah, T., McNutt, R.W., Chang, K.J., and Porreca, F. (1993). Antinociceptive actions of BW373U86 in the mouse. J. Pharmacol. Exp. Ther. 267, 858-865.
42. Zheng, M., and Pintar, J.E. (1995). Analysis of ontogeny of processing enzyme gene expression and regulation. Methods Neurosci. 23, 45-64.
43. Zhu, Y., and Pintar, J.E. (1998). Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. Biol. Reprod. 59, 925-932.
44. Zhu, Y., Hsu, M., and Pintar, J. (1998). Developmental expression of the μ, κ, and δ opioid receptor mRNAs in mouse. J. Neurosci. 18, 2538-2549.